Cryptocurrency Analysis and News Portal
For the Pfizer and BioNTech coronavirus vaccine to be approved by the U.S. FDA, they will have to provide the regulatory body with at least two months of safety data.Shares of Pfizer Inc (NYSE: PFE) jumped approximately 2.19% during Friday’s pre-market to trade around $37.36, they continued their growth as
Read More
The start of the review process of the BioNTech-Pfizer vaccine has triggered investors to bet more on BNTX stock.The European Union’s European Medicines Agency (EMA) has commenced the review of BNT162b2, the BioNTech-Pfizer COVID-19 vaccine candidate being developed by the duo of BioNTech SE (NASDAQ: BNTX) and Pfizer Inc (NYSE:
Read More
The U.S. Government has signed a $1.95 billion deal with Pfizer and BioNTech for their COVID-19 vaccine. The prices PFE and BNTX stocks are moving higher.The United States has agreed to pay Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) $1.95 billion for a safe and effective coronavirus vaccine.
Read More
Pfizer and BioNTech stocks have jumped in response to receiving ‘Fast Track’ status on their coronavirus vaccine candidates. PFE and BNTX prices are rising.Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) stocks surged after the Food and Drug Administration (FDA) gave the companies’ joint coronavirus vaccine candidates a Fast
Read More